4//SEC Filing
Poliakoff Abba David 4
Accession 0001628280-21-001615
CIK 0000771856other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:46 PM ET
Size
15.8 KB
Accession
0001628280-21-001615
Insider Transaction Report
Form 4
Poliakoff Abba David
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-19$3.21/sh+10,000$32,100→ 80,147 total - Exercise/Conversion
Option to purchase Common Stock
2021-01-19−10,000→ 0 totalExercise: $3.21Exp: 2022-10-31→ Common Stock (10,000 underlying) - Tax Payment
Common Stock
2021-01-19$11.53/sh+8,873$102,306→ 81,274 total - Exercise/Conversion
Common Stock
2021-01-19$5.43/sh+10,000$54,300→ 90,147 total - Exercise/Conversion
Common Stock
2021-01-19$1.59/sh+10,000$15,900→ 70,147 total - Exercise/Conversion
Option to purchase Common Stock
2021-01-19−10,000→ 0 totalExercise: $5.43Exp: 2024-11-04→ Common Stock (10,000 underlying) - Exercise/Conversion
Option to purchase Common Stock
2021-01-19−10,000→ 0 totalExercise: $1.59Exp: 2021-11-01→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]Represents a "net exercise" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on January 19,2021.
- [F2]The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017 respectively.
- [F3]The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2017, February 1, 2018, May 1, 2018 and August 1, 2018, respectively.
- [F4]The options vest and are exercisable over a twelve month period, with vesting to occur on November 4, 2019, February 4, 2020, May 4, 2020 and August 4, 2020, respectively.
Documents
Issuer
CHAMPIONS ONCOLOGY, INC.
CIK 0000771856
Entity typeother
Related Parties
1- filerCIK 0001423066
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:46 PM ET
- Size
- 15.8 KB